Work

COVID-19 Outcomes in Stage IV Cancer Patients Receiving Immune Checkpoint Inhibitors

Year: 2022

Type: article

Study design: Observational Study

Source: SN Comprehensive Clinical Medicine

DOI: 10.1007/s42399-022-01277-z

Authors: Mengni Guo, Jieying Liu, Shuntai Zhou, James Yu, Zohaib Ahmed, Sarfraz Ahmad, Manoucher Manoucheri, Mark A. Socinski, Tarek Mekhail, Vincent Hsu

Institutions: AdventHealth Orlando, University of North Carolina at Chapel Hill, AdventHealth

Language: English

Topic: COVID-19 and healthcare impacts

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4293200002

FWCI:

Cites: 42

Cited by:

Related to: 10